Product Reports Resources Pricing Login Book a demo

Resilience

Biotech & Life Sciences · San Diego, United States · Founded 2020

Broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption

Valuation $2.5–5B
Revenue $500M–1B
Headcount 1–2k
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Resilience and the history behind them.
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue

Investors

7 investors on Resilience's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
GV
Series B+ 6 investors entered at this stage
NEA
Eli Lilly
8VC
ARCH Venture Partners
Mubadala Capital
Lux Capital

Resilience mafia

Startups founded by Resilience alumni

Former Resilience employees who went on to start their own companies. Sorted by Dealroom signal score.

BioptimusEst. 2023
Thomas ClozelFrance
Signal score93
Ridge BiotechnologiesEst. 2025
Weston KightlingerUnited States
Signal score90
PotatoEst. 2023
Nick Edwards, PhDUnited States
Signal score86
Verse TherapyEst. 2023
Danielle YoesepUnited States
Signal score50

Book a demo to explore the full alumni network →

Global footprint

Where Resilience has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States80.8%
🇨🇦 Canada18.3%
🇦🇪 United Arab Emirates0.2%
🇮🇳 India0.2%
🇬🇧 United Kingdom0.1%
Top 5 of 6 shown
Web traffic by country
19K monthly visits
across markets
🇺🇸 United States68.9%
🇨🇦 Canada18.9%
🇮🇳 India5.8%
🇸🇦 Saudi Arabia2.6%
🇬🇧 United Kingdom1.6%
Top 5 markets shown

Talent graph

The shape of Resilience's talent

Dealroom maps Resilience's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

9 standout operatorsDealroom-flagged across the org
6 AI specialistsincl. 3 core researchers
1,304 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Resilience's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$25M patent portfolio · 24 active families

Estimated portfolio value
$25M
0.66% of valuation · 5.1× smaller than top peer Zymeworks ($125M)
24 active patent families
Where Resilience innovates BioinformaticsCellGeneHemoglobinMolecular biology

Where Resilience concentrates vs peers

Each axis is a top-10 topic across Resilience and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Resilience's 5 investments and acquisitions.

Every disclosed deal where Resilience appeared as a backer or acquirer, 2021–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Resilience's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Resilience deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Resilience's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        What the market is saying about Resilience

        An AI-synthesized read of the highest-engagement posts about Resilience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Resilience on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles